CapRock Research Initiates Analyst Coverage on Livedeal with $7.15 Price Target Issued By Small Cap Traders and 4 Brief Reports
Datum : 19/02/2015 @ 12h30
Quelle : InvestorsHub NewsWire
Name : Amarin Corp. Plc ADS, Each Representing One Ordinary Share (MM) (AMRN)
Kurs : 1.43 0.12 (9.16%) @ 13h58
§
CapRock Research Initiates Analyst Coverage on Livedeal with $7.15 Price Target Issued By Small Cap Traders and 4 Brief Reports
Print
Alert
NEW YORK, NY -- February 19, 2015 -- InvestorsHub NewsWire -- SmallCapTraders.com initiates coverage of LiveDeal, Inc. (NASDAQ: LIVE)
This week’s feature profile has a great chart setup with uptrend forming and a recent pull back to breathe a little here for the next run up.
Couple that with this announcement last week- “Largest Quarterly Sales and Biggest Increase in Revenue in Company History”
Full press release: www.prnewswire.com/news-releases/...any-history-291645661.html
LiveDeal, Inc. (NASDAQ: LIVE) “Simple yet genius marketing company”
Highlights
• Company announces record revenues and revenue increase for the December 31, 2014 quarter.
• Company has created over 10,000 deals for over 8,000 clients in over 50 cities nationwide.
• Company added 4,457 new restaurant deals during the fourth quarter of fiscal 2014, up over 1,100 deals sequentially.
Great potential here with LIVE for a short squeeze in the near term.
LIVE Full Profile:
smallcapir.com/?p=2666
4 Brief Reports:
InterDigital, Inc. (NASDAQ: IDCC) develops technologies that are at the core of mobile devices, networks, and services worldwide. We solve many of the industry's most critical and complex technical challenges, inventing solutions for more efficient broadband networks and richer multimedia experience years ahead of market deployment. InterDigital has licenses and strategic relationships with many of the world's leading wireless companies.
The company's stock will be added to the NASDAQ US Buyback Achievers Index and a company executive has been named to a prestigious Board. Read about these developments in this report: bit.ly/-IDCC-AnalystBrief
FXCM, Inc. (NYSE: FXCM) is a global online provider of foreign exchange (forex) trading and related services to retail and institutional customers world-wide. At the heart of FXCM's client offering is No Dealing Desk forex trading. Clients have the advantage of mobile trading, one-click order execution and trading from real-time charts. FXCM's U.K. subsidiary, Forex Capital Markets Limited, also offers CFD products with no re-quote trading and allows clients to trade oil, gold, silver and stock indices along with forex on one platform.
After the disruption caused by the drastic movement of the Swiss Franc in January, the company has updated some of its recent operating metrics. Read about it here in this report: bit.ly/-FXCM-AnalystBrief
Amarin Corp, PLC. (NASDAQ: AMRN) is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. Amarin's product development program leverages its extensive experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids.
Vascepa® (icosapent ethyl), Amarin's first FDA-approved product, is an ultra-pure, EPA-only omega-3 fatty acid product available by prescription.